Trian Partners founder and CEO Nelson Peltz has nominated himself and former Disney CFO Jay Rasulo to Disney's board as part of his ongoing proxy fight with the entertainment giant.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) today announced that the European Commission (EC) has extended the approval of Evkeeza® (evinacumab) as an adjunct to diet and other lipid-lowering therapies to treat